Skip to main content
. 2022 Feb 8;11:e74365. doi: 10.7554/eLife.74365

Figure 7. Cx43(M1) impedes the loading-induced increased PGE2 secretion and osteoblast activity, and decreased osteoclast activity.

(a) ELISA analysis of PGE2 in bone marrow-flushed tibial diaphysis after 5 days of mechanical loading in vehicle and Cx43(M1)-treated mice (n = 8/group). (b, c) Representative images and quantitative analysis of COX-2-postive osteocytes (yellow arrows) in tibial midshaft cortical bone after 2 weeks of loading in vehicle and Cx43(M1)-treated mice. Scale bar: 30 μm. n = 8–9/group. (d) Ptgs2 mRNA determined by RT-qPCR in bone marrow-flushed tibial diaphysis of vehicle and Cx43(M1)-treated mice. n = 4/group. (e, f) Representative images and quantitative analysis of the SOST-positive osteocytes (yellow arrows) in tibial midshaft cortical bone after 2 weeks of mechanical loading in vehicle and Cx43(M1)-treated mice. Scale bar: 30 μm (n = 8/group). (g) Sost mRNA determined by RT-qPCR from bone marrow-flushed tibial diaphysis of vehicle and Cx43(M1)-treated mice. n = 4/group. (h, i) Representative images and quantitative analysis of the β-catenin-positive periosteal cells (black arrows) on tibial midshaft endosteal surface after 2 weeks of loading in vehicle and Cx43(M1)-treated mice. Scale bar: 20 μm; n = 5–6/group. (j) Ctnnb1 mRNA determined by RT-qPCR in bone marrow-flushed tibial diaphysis of vehicle and Cx43(M1)-treated mice. n = 4/group. (k) Representative images of tibial midshaft endosteal surface stained for toluidine blue (top panel) or TRAP (low panel). The yellow arrows indicate osteoblasts and the black arrows indicate the TRAP-positive osteoclasts. Scale bar: 30 μm. (l) Histomorphometric quantitation of osteoblast per bone perimeter (n = 5–7/group). (m) Bglap2 mRNA determined by RT-qPCR in bone marrow-flushed tibial diaphysis of vehicle and Cx43(M1)-treated mice. n = 4/group. (n, o) Histomorphometric quantitation of osteoclast per bone perimeter (n) and osteoclast surface per bone perimeter (o) (n = 5–7/group). Data are expressed as mean ± SD. *, p < 0.05; **, p < 0.01; ***, p < 0.001. Statistical analysis was performed using paired t-test for loaded and contralateral within each treatment.

Figure 7—source data 1. Raw data of PGE2 level for Figure 7a.
Figure 7—source data 2. Raw data of immumohistochemical, TRAP and toluidine blue staining of vehicle and Cx43(M1)-treated mice.
Figure 7—source data 3. Raw data of RT-qPCR of vehicle and Cx43(M1)-treated mice.

Figure 7.

Figure 7—figure supplement 1. Bone marker protein expression in vehicle- and Cx43(M1)-treated mice.

Figure 7—figure supplement 1.

(a, b) Quantitative analysis of the COX-2-positive or SOST-positive osteocytes per bone area in tibial midshaft cortical bone after 2 weeks of loading in vehicle and Cx43(M1)-treated mice. n = 8–9/group. (c) Quantitative analysis of the β-catenin-positive osteoblasts per bone perimeter in tibial midshaft cortical bone after 2 weeks of mechanical loading in vehicle and Cx43(M1)-treated mice. n = 4–6/group. Data are expressed as mean ± SD. *, p < 0.05; **, p < 0.01; ***, p < 0.001. Statistical analysis was performed using paired t-test for loaded and contralateral within each treatment.
Figure 7—figure supplement 1—source data 1. Raw data of COX-2, SOST, and β-catenin quantification for Figure 7—figure supplement 1a-c.